Nxera Pharma Co., Ltd. (4565) Other
Market cap
¥94.6B
P/E ratio
Nexera Pharma discovers, develops and commercializes innovative specialty pharmaceuticals to improve patient quality of life in Japan and worldwide.
| 2012/03 | 2013/03 | 2014/03 | 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | 2025/12 | |
| Return on Assets | - | - | - | - | -3 | 20.2 | -4.5 | -11.2 | 2.3 | 4.7 | 3.3 | 3.7 | -0.2 | -0.9 | -5.4 |
| Return on equity (%) | - | - | - | ||||||||||||
| Employees | 26 | 27 | 30 | 106 | 116 | 145 | 152 | 169 | 163 | 190 | 198 | 202 | 350 | 374 | 382 |